Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) SHH

Currency In CNY

AD

Valuation

Market Cap13.55B
Enterprise Value10.73B
P/E Ratio16.8
PEG Ratio-0.46
Price/Sales Ratio1.34
Price/Book Ratio0.85
Enterprise/Revenue1.07
Enterprise/EBITDA6.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.11
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue9.36B
Revenue/Share6.58
Gross Profit3.04B
EBITDA2.08B
Net Income944.38M
Diluted EPS0.7

Balance Sheet

Total Cash3.72B
Total Cash/Share2.78
Total Debt1.3B
Total Debt/Equity0.09
Current Ratio3.59
Book Value Per Share11.96

Price History

52-Week Change-22.73
52-Week High11.78
52-Week Low7.67
Moving Average 50 Days8.72
Moving Average 200 Days9.92

Statistics

Average Volume9.36M
Shares Outstanding1.34B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield3.39
Payout Ratio0.55
Last Split Factor2:1
Last Split DateMay 25, 2017
AD